Skip Navigation

Sagar Lonial, MD

Professor
Emory School of Medicine

Vice Chair of Clinical Affairs
Department of Hematology & Medical Oncology

Director
Translational Research, B-cell Malignancy Program

Dr. Lonial is an Associate Professor at the Winship Cancer Institute of Emory University, Director of Translational Research, B-cell malignancy program as well as Associate Director of Hematology Oncology Fellowship Program. He staffs and works both on the transplant service as well as in the B-cell malignancy clinic.

Dr. Lonial completed his Hematology-Oncology training at Emory University, and prior to that received his internal medicine residency at the Baylor College of Medicine in Houston Texas. There he spent an additional year as a Chief Medical Resident at the Ben Taub General Hospital as well as the Texas Heart Institute and St Lukes Hospital.

Dr. Lonial is on the editorial board for Clinical Lymphoma and Myeloma and The American Journal of Clinical Oncology, as well as an ad hoc reviewer for Blood, Cancer Research, Clinical Cancer Research, Haematologica, and other journals. He has authored or co-authored over 40 papers and abstracts, and was recently appointed to Vice-chair for the ECOG myeloma committee.

Full Clinical Bio >>

Research Interests

Dr. Lonial has worked in the field of immunotherapy and cancer since his arrival at Emory, and in the previous 3 years has spent time developing the B-cell malignancy program with respect to novel targeted agents in laboratory models as well as early clinical trials. Dr. Lonial’s previous laboratory work has focused on evaluating the impact of purified dendritic cell subsets on the nature of immune responses against antigen, and he has completed several trials evaluating the impact of cytokines on dendritic cell content and post transplant immune recovery. Most recently, Dr. Lonial has focused on combinations of novel agents as therapy for myeloma and lymphoma, particularly evaluating combinations that may result in synergistic inhibition of the PI3-K/Akt pathway. His lab has recently received funding from the MMRF, the Lymphoma Research Foundation, and the Leukemia and Lymphoma Society.



Publications

View publications on PubMed

Clinical Trials

View clinical trials at Winship Cancer Institute

Grants